a Department of Health and Human Services , Office of the Chief Psychiatrist , Melbourne , Victoria , Australia.
b Department of Psychiatry , Monash University , Melbourne , Victoria , Australia.
Aging Ment Health. 2018 Nov;22(11):1432-1437. doi: 10.1080/13607863.2017.1366418. Epub 2017 Aug 28.
To develop indicators of safe psychotropic prescribing practices for people with dementia and to test them in a convenience sample of six aged mental health services in Victoria, Australia.
The clinical records of 115 acute inpatients were checked by four trained auditors against indicators derived from three Australian health care quality and safety standards or guidelines. Indicators addressed psychotropic medication history taking; the prescribing of regular and 'as needed' psychotropics; the documentation of psychotropic adverse reactions, and discharge medication plans.
The most problematic areas concerned the gathering of information about patients' psychotropic prescribing histories at the point of entry to the ward and, later, the handing over on discharge of information concerning newly prescribed treatments and the reasons for ceasing medications, including adverse reactions. There were wide variations between services.
The indicators, while drawn from current Australian guidelines, were entirely consistent with current prescribing frameworks and provide useful measures of prescribing practice for use in benchmarking and other quality improvement activities.
为痴呆症患者制定安全精神药物处方实践的指标,并在澳大利亚维多利亚州的六个老年心理健康服务机构的便利样本中对其进行测试。
四名经过培训的审核员根据三项澳大利亚医疗质量和安全标准或指南中的指标,检查了 115 名急性住院患者的临床记录。这些指标涉及精神药物用药史、定期和“按需”精神药物的开具、精神药物不良反应的记录以及出院用药计划。
最成问题的领域涉及在进入病房时收集有关患者精神药物处方史的信息,以及后来在出院时转交有关新开具治疗药物的信息以及停止用药的原因,包括不良反应。各服务之间存在很大差异。
这些指标虽然来自当前的澳大利亚指南,但与当前的处方框架完全一致,为用于基准测试和其他质量改进活动的处方实践提供了有用的衡量标准。